BEHIND RIABNI™ The Amgen Distinction

RIABNI™—like all of the Amgen Oncology products—is made to meet rigorous standards.

  • DEEPLY ROOTED experience that can't be replicated

    40 years of experience in biologics

    STATE-OF-THE-ART MANUFACTURING INFRASTRUCTURE FOR
    HIGH QUALITY BIOLOGICS

    image description

    Amgen products are treating patients ACROSS THE GLOBE1

    I was actually very excited [about Amgen Biosimilars] because Amgen has a very long experience in manufacturing biologics.

    – Dr Lee Schwartzberg, Oncologist
  • A PROVEN ONCOLOGY BIOLOGICS LEADER WITH A TRACK RECORD OF RELIABLE SUPPLY

    Between 2007 and 2018, Amgen has achieved zero supply shortages

    AMGEN HAS AN UNINTERRUPTED SUPPLY RECORD ThROUGH MULTIPLE NATURAL DISASTERS AND DURING COVID-192,3

    I want a manufacturer who's got experience and has got enough scale to supply me with the product in an uninterrupted fashion. My patients deserve that and need that.

    – Dr Lee Schwartzberg, Oncologist
    • *Between 2007 and October 2020.
  • COMMITTED TO A PIPELINE OF INNOVATOR BIOLOGICS AND BIOSIMILARS

    27 oncology biologics and 6 biosimilars currently in development
    image description

    AT AMGEN, WE UNDERSTAND HEALTHCARE PRACTICE ECONOMICS. THAT'S WHY WE'RE A PROVEN LONG-TERM PARTNER

    When we choose a manufacturer, we look at product portfolio. If they are heavy in oncology and biologics, then we know that they know what they're doing.

    – Chris Marcum, Pharmacist
  • A single source of dedicated support for all amgen oncology products

    Amgen ASSIST 360
    image description
    AMGEN REIMBURSEMENT SPECIALISTS
    image description
    PATIENT RESOURCE GUIDE
    image description
    BENEFIT VERIFICATION
    Amgen First Step
    image description
    Amgen Assist 360™
    Nurse Navigators
    Call 1-888-4ASSIST
    (1-888-427-7478)
    Amgen Safety Net Foundation

    A nonprofit patient assistance program sponsored by Amgen that helps qualifying patients access Amgen medicines, including RIABNI™, at no cost.

    image description

    4200+ patients are SUPPORTED BY AMGEN ASSIST 360™ FOR KANJINTI® AND MVASI®5,*

    • *As of March 2021.

    Amgen does have a large support network and plenty of data available to help guide providers and pharmacists through some of these switches over from the reference product to a biosimilar.

    – Chris Marcum, Pharmacist
    • *As of March 2021.

    Learn more about support & resources

logo-amgen-biosim
Get the story behind Amgen's commitment to biosimilars

See the totality of evidence behind RIABNI™